GSK ties up with gene editing start-up Mammoth for COVID-19 test
May 20, 2020 at 12:00 PM EDT
GlaxoSmithKline's consumer health unit has tied up with Mammoth Biosciences to develop a test that uses a technology commonly used in gene editing to detect novel coronavirus infections, the California-based startup said on Wednesday.